|
INO80D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.316500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.191500E-04 |
| Normal-vs-Stage2 |
1.109040E-01 |
| Normal-vs-Stage3 |
8.799600E-02 |
| Normal-vs-Stage4 |
5.416400E-01 |
| Stage1-vs-Stage2 |
7.804000E-01 |
| Stage1-vs-Stage3 |
1.509640E-01 |
| Stage1-vs-Stage4 |
6.102300E-03 |
| Stage2-vs-Stage3 |
5.823400E-01 |
| Stage2-vs-Stage4 |
2.212000E-01 |
| Stage3-vs-Stage4 |
2.769000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.575600E-03 |
| Normal-vs-AfricanAmerican |
4.291800E-01 |
| Normal-vs-Asian |
5.478200E-03 |
| Caucasian-vs-AfricanAmerican |
1.195760E-01 |
| Caucasian-vs-Asian |
2.077400E-01 |
| AfricanAmerican-vs-Asian |
3.970100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.325900E-02 |
| Normal-vs-Female |
2.173900E-04 |
| Male-vs-Female |
1.846470E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.167400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.993000E-04 |
| Normal-vs-Age(61-80Yrs) |
6.172500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.237400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.035400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.034600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.825000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.347900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.365000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.683700E-03 |
| Normal-vs-Grade 2 |
4.18180000000268E-05 |
| Normal-vs-Grade 3 |
1.086550E-01 |
| Normal-vs-Grade 4 |
6.140000E-01 |
| Grade 1-vs-Grade 2 |
6.162200E-01 |
| Grade 1-vs-Grade 3 |
4.388100E-02 |
| Grade 1-vs-Grade 4 |
2.461700E-03 |
| Grade 2-vs-Grade 3 |
2.662600E-03 |
| Grade 2-vs-Grade 4 |
1.52876999999219E-05 |
| Grade 3-vs-Grade 4 |
3.100100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.82560000006049E-07 |
| Normal-vs-ccB subtype |
3.475200E-01 |
| ccA subtype-vs-ccB subtype |
2.9727000000479E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.844300E-03 |
| Normal-vs-N1 |
7.273000E-01 |
| N0-vs-N1 |
1.752760E-01 |
|
|
